Purpose: Transient hypogammaglobulinemia of infancy (THI) is a common immunodeficiency, but definitive diagnosis can only be made retrospectively. While the pathogenesis is still unknown, abnormalities have been reported in the B cell compartment. In this study, we analysed the B cell subsets of patients with an initial THI diagnosis (n = 20) and compared them with those of healthy agematched Turkish children (n = 72). Methods: Flow cytometric analyses of the B subsets were performed by staining with anti-CD27-PE, anti-CD19-PerCP, anti-IgD-FITC and anti-IgM-APC antibodies. Results: During a median follow-up of 6.6 years, 13 patients whose IgG levels had normalized before they reached four years of age were diagnosed with definitive THI. The memory subsets of these patients were lower but not statistically different from the healthy controls (HC). The remaining seven patients had prolonged hypogammaglobulinemia after the age of four and had significantly lower memory B cell subsets compared to the HC. On follow-up, these patients had not experienced recurrent infections or autoimmunity. Re-evaluation of patients' B cell subsets six years later showed that the memory B cell ratios had increased to levels comparable to HC, despite the patients still having mildly low IgG levels. Conclusion: Patients with prolonged hypogammaglobulinemia had lower levels of memory B cells despite having a similar clinical course to patients who had been diagnosed with definitive THI. This subgroup of putative THI patients poses a diagnostic and classification dilemma. Our results suggested that these patients' memory B cells and IgG levels may recover over time.
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| INTRODUCTION
Transient hypogammaglobulinemia of infancy (THI) is defined as a delay in immunoglobulin synthesis, particularly immunoglobulin G (IgG). It is also defined as a prolongation of physiological hypogammaglobulinemia during infancy without the impairment of specific antibody responses. 1 According to a recent study, THI is one of the most common immunodeficiency diagnoses, affecting 24% of children with hypogammaglobulinemia. 2 THI is considered a transient immunodeficiency, in which the immunoglobulin deficiency generally recovers when the patient is between 2 and 4 years of age. However, recent studies have shown that in some children, hypogammaglobulinemia may persist into late childhood or even adulthood. In these instances, it has been classified as idiopathic primary hypogammaglobulinemia (IPH), undefined/unclassified hypogammaglobulinemia or other hypogammaglobulinemias by different groups. [3] [4] [5] However, none of these diagnoses are included in the IUIS classifications. 6 Definitive THI diagnosis can only be made retrospectively in an infant who has been admitted to a clinic with recurrent infections and hypogammaglobulinemia after excluding the clinical and laboratory features of well-defined immune-deficiencies. Currently, it is impossible to predict which infant or child will recover from hypogammaglobulinemia and which will suffer from a more severe disease such as common variable immunodeficiency (CVID). 7 The mechanism of THI pathogenesis is still unknown. Aberrant cytokine production or a defect in helper T cells function has previously been theorized. [8] [9] [10] [11] Recently, abnormalities in the B cell compartment have been reported in THI patients compared to healthy children. Specifically, decreased expression of the CD19 complex and decreased numbers of memory B cells, especially decreased numbers of class-switched memory B (CSMB) cells and IgM memory B cells, have been noted. 12, 13 A decreased CSMB cell ratio has been reported as the most frequently detected abnormality also in CVID patients, where characterization of B lymphocytes by flow cytometry was used for categorization. [14] [15] [16] During their development, the immature B cell precursors in the bone marrow migrate to the periphery as transitional B cells. In the spleen, they acquire a mature phenotype and functions and become naive mature B cells (CD19 17, 18 B cell subsets change with age. There are limited studies on B cell subsets in healthy children and in THI/ undefined hypogammaglobulinemia/idiopathic primary hypogammaglobulinemia patients. [19] [20] [21] [22] [23] In this study, we aimed to determine the B cell subsets of patients with an initial THI diagnosis (n = 20) and compared them with those of age-matched healthy Turkish children (n = 72). We also presented follow-ups and re-evaluations of the patients and their B cell subsets. Six years later, we re-evaluated the patients' clinical findings and IgG levels. Patients whose IgG levels had normalized before they reached 4 years of age were diagnosed with definitive THI. 7, 25 Healthy controls for B cell subset analysis were recruited among children who had been admitted to the paediatric clinics and evaluated as healthy with history, physical examination and routine laboratory tests including complete blood count. In the first B lymphocyte analysis, we studied the peripheral B subsets of 20 and 72 healthy controls in five age groups, divided as: Group 1 (0-2 years), Group 2 (2-4 years), Group 3 (5-7 years), Group 4 (8-10) and . Reference values of the B subsets of the healthy children are provided in Table 1 .
The initial indications for measuring the immunoglobulin levels in all study patients were recurrent upper or lower respiratory tract infections, recurrent otitis media or gastroenteritis. The following parameters were recorded: the patient's age at the onset of infections, diagnosis of hypogammaglobulinemia, hospitalizations, the presence of consanguinity and a history of allergic diseases, atopy and other systemic diseases.
Approval was obtained from the Institutional Ethics Committee of Hacettepe University (GO 09250-150). All patients and/or parents provided signed informed consent.
| Laboratory studies
Total serum immunoglobulin levels of the study patients and the healthy controls were measured using the turbidimetric method, and the reference ranges of healthy Turkish children were used. 26 Serum IgE levels were measured using an immunoassay method. Anti-HBs and antipneumococcal polysaccharide antibody levels were evaluated as indicators of the patient's antibody response and measured by ELISA. The following criteria indicated a positive response: anti-HBs antibody levels above 10 IU/ mL; a more than twofold increase or >10 U/mL of antibody titre against five out of eight pneumococcal serotypes after administration of an unconjugated pneumococcal vaccine. An isohaemagglutinin titre above 1/16 was accepted as positive in non-AB blood group patients. Flow cytometric analyses of the peripheral lymphocyte subsets and the B cell subsets were evaluated by the whole blood method. 27 Gating strategy was provided in Figure S1 . The stainings were performed using the following antibodies: anti-CD27-PE (BD Bioscience), anti-CD19-PerCP (BD Bioscience), anti-IgD-FITC (BD Bioscience) and anti-IgM-APC (BD Bioscience 
| RESULTS

| Clinical and laboratory features of patients
All the patients were admitted to our clinic with a history of recurrent upper or lower respiratory tract infections. The median age at the onset of recurrent infections was 6 months, and the median age of hypogammaglobulinemia diagnosis was 13 months (Table 2) . Six (30%) of the patients were hospitalized with pneumonia and four (20%) experienced bronchiolitis for once. Half of the patients had been assigned the diagnosis of wheezy infant. All were evaluated for specific IgE levels and/or with a skin prick test, but none had atopy. None of the patients had symptoms or findings of autoimmunity or severe infections. On follow-up, two patients were given antibiotic prophylaxis and one, whose IgG levels had normalized by the age of 17 months, was given monthly intravenous immunoglobulin treatment for 6 months. The frequency of parental consanguinity was 25%, similar to that of the Turkish population. 28 First-degree relatives of three patients who were diagnosed with THI had a history of recurrent infections, but none of them had an immunodeficiency. All patients produced anti-HBs antibodies and had normal isohaemagglutinins. Five patients who were older than 35 months were evaluated for a polysaccharide antibody response 4 weeks after vaccination with an unconjugated pneumococcal vaccine; they were found to have normal antibody responses.
All patients had low IgG levels upon admission to our clinic and were diagnosed as putative THI according to the criteria listed above. During follow-up, 13 patients (median 3.3 years of age) were diagnosed with THI; their IgG levels normalized in median 20 months (5-35 months).
Seven patients' (median 6.2 years of age) IgG levels increased but were mildly lower than the 5 th percentile at their last visit [median 742 mg/dL (525-838 mg/dL)]. These patients did not have CVID phenotypes (severe recurrent infections, autoimmunity, polyclonal lymphoproliferation), but had normal antibody responses. There was no significant correlation between the initial serum IgG levels and the IgG normalization time (n = 13) (r = −3.81, P = 0.459). Also, there was no significant difference in initial serum IgA, IgM and IgG levels between the definitive THI patients (n = 13) and the patients with persistently low IgG levels (P = 0.067, P = 0.097, and P = 0.347, respectively).
| B cell subsets in the study patients and the healthy controls
We studied the B cell subsets of 20 patients with a putative THI diagnosis, compared them with those of 72 healthy children aged 0-17 years and determined age-related changes (Table 1) . In group 1, the B cell subsets of eight patients were compared with those of 16 controls; in group 2, the B cell subsets of five patients were compared with those of seven controls; and in group 3, the B cell subsets of seven patients were compared with those of 17 controls.
The ratio of CD19 + B lymphocytes, a common B cell marker, decreased with age both in the controls (r = −0.363, P = 0.022) and in the patients (r = −0.434, P = 0.05); we did not detect a statistically significant difference between the patients and the controls ( Figure 1A) . The naive B cell ratio also decreased with age in the controls (r = −0,485, P < 0.001) and in the patients (r = −0.899, P < 0.001); there was no statistically significant difference between the patients and the controls in all age groups ( Figure 1B) . The ratio of MZ B cells did not significantly differ with age both in the patients (r = 0.1, P = 0.92) and in the controls (r = 0.048, P = 0.840) ( Figure 1C) . The MZ B cell ratio of the patients in group 2 was significantly lower compared to the healthy controls (P = 0.028), but there was no statistically significant difference in the other groups. CD27 is a memory B cell marker. We found that the CD27 + B lymphocyte ratio increased significantly with age both in the patients (r = 0.660, P = 0.002) and in the controls (r = 0.507 and P < 0.001) ( Figure 1D ). The memory B cell subset ratios, including CD27 + B cells, CSMB cells
and IgM memory B cells, were lower but not statistically different in the patients in groups 1 and 2 compared to the controls; however, these ratios were significantly lower in the patients in group 3 (with persistently low IgG levels) ( Figure 1D , E and F). Six years after the initial B subset analysis, two patients were lost to follow-up. We reanalysed the B subsets of five out of seven patients who had still low IgG levels (group 3). The CD27 + B and CSMB cell ratios of these five patients had significantly increased (P = 0.043) (Figure 2 ) to levels comparable to those of age-matched controls (P = 0.513 and 0.190, respectively).
| DISCUSSION
In children, peripheral B cells mainly consist of transitional B cells, mature naive B cells and memory B cells (CD27 + cells), with mature naive B cells being the most prevalent. 18 Naive B cells decrease with age while memory B cells increase, demonstrating the importance of using B cell subsets from an age-matched healthy control group for disease analysis. This study included one of the highest reported numbers of healthy Turkish children for the analysis of B lymphocyte subsets in different age groups. 19 The results showed age-dependent changes similar to those described in previous studies.
19-23
The patients comprised 20 children with putative THI. After the median follow-up period of 6.6 years, 13 patients (65%) were diagnosed with definitive THI. The patients with definitive THI had decreased but statistically insignificant memory B cells. Meanwhile, the patients who were aged between 5 and 7 years at the initial analysis and had persistent hypogammaglobulinemia at the follow-up showed significantly decreased memory B cells compared to age-matched healthy controls ( Figure 1D, 1E,1F) . None Flow cytometric analysis of B cell subsets in patients with low IgG during infancy has been suggested to help clinicians with the differential diagnosis of primary antibody deficiencies. 13 Previous studies and ours may provide some guidance for clinicians, 12, 13, 20 but due to the small number of patients in our study, it is not possible to make a clear distinction between patients who will recover and those who will have persistent hypogammaglobulinemia. Transient hypogammaglobulinemia of infancy is classified under the subheading of other hypogammaglobulinemias in the IUIS classification. 6 However, there is still no consensus on the categorization of children who have persistent hypogammaglobulinemia until late childhood without a well-defined immunodeficiency. These patients are referred under various definitions as unclassified hypogammaglobulinemia, IPH and possible CVID. [3] [4] [5] 20 Previously reported patients with persistent hypogammaglobulinemia have not presented homogenous clinical and laboratory features. Some patients had more aspects of the CVID phenotype with severe recurrent infections and complications, lymphadenopathy and autoimmunity. 20, 29 Others had a benign clinical course with only non-severe recurrent infections. [3] [4] [5] 8, 24, 30 Our study patients with persistent hypogammaglobulinemia resembled the latter group. The B subset pattern has been scarcely studied in these patients. Bukowska-Strakova et al 17 showed that B cell subsets were normal during the entire period of hypogammaglobulinemia in children with THI, whereas the persistence of low memory B cell subsets in some children, particularly after 5 years of age, may facilitate the diagnosis of CVID. When we re-evaluated our patients who had significantly lower memory B cells, 6 years after the initial analysis, we found that the B cell subset ratios had increased to levels comparable to the age-matched healthy controls. The patients' IgG values had also increased but were still mildly low. We evaluated the patients' detailed T lymphocyte subsets and found no additional abnormalities consistent with any well-known immune-deficiencies (data not shown). There is still a possibility that this prolonged THI may be the first sign of one of a yet undescribed or many newly described immune-deficiencies that involve more than just antibody deficiency. These patients may present with immunodeficiency-related problems later in life, so they should be followed-up over the long-term. Driessen et al 20 classified 21 adult IPH patients according to their B cell patterns and showed that 67% of these patients had normal memory B cells (defined as greater than the 5 th percentile of healthy controls); the remaining 33% had either reduced memory B cells (defined as lower than the 5 th percentile of healthy controls) or marginal B cells. However, this patient group mainly included adult patients with recurrent infections, such as severe pneumonia and bronchiectasis. We believe that our study patients shown in Table 1 6 of 8 | with persistently low IgG may define children with a delayed B cell development that is different from Driessen's cohort. Although this single-centre study included a limited number of patients, the results suggest that some patients may recover over time, even those with significantly lower memory B cells and prolonged low IgG levels. Prospective studies with a larger number of patients and a longer follow-up period may shed light on the pathogenesis and differential diagnosis of these patients.
| CONCLUSION
In the present study, we did not find significant differences in the B subsets between definitive THI patients and healthy controls, but patients who had persistent hypogammaglobulinemia after the age of 4 years had significantly lower memory B cells. The clinical course of these patients was similar to that of patients with definitive THI; their memory B cells and IgG levels recovered over time. This subgroup of putative THI patients poses a diagnostic and classification dilemma. These patients may represent a yet undescribed or one of a newly described immune-deficiency. They should be followedup over the long-term and intermittently re-evaluated for definitive diagnosis.
